Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes
Open Access
- 16 September 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 74 (5), 941-942
- https://doi.org/10.1093/cid/ciab618
Abstract
Lynne V McFarland, Ravina Kullar, Pierre-Jean Maziade, Ellie J C Goldstein; Why two studies using the same probiotic may have come up with different outcomes, CThis publication has 5 references indexed in Scilit:
- A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile InfectionClinical Infectious Diseases, 2021
- Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic TherapyClinical Infectious Diseases, 2021
- Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic UseAntibiotics, 2021
- Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidenceAmerican Journal of Infection Control, 2020
- Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisFrontiers in Medicine, 2018